IQVIA Holdings (FRA:QTS) Short Interest


FRA:QTS IQVIA Holdings Inc FRA:QTS
88 GF Score
Price €164.40
GF Value €220.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:QTS vs NTRA, ILMN, MTD: Short Interest Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Short Interest falls into.


FRA:QTS
88GF Score
IQVIA Holdings Inc FRA:QTS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IQVIA Holdings (FRA:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €164.40 is trading 25.5% below its estimated GF Value™ of €220.53. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for FRA:QTS:

  • Short Interest:
  • GF Value™: €220.53 vs. price of €164.40 (25.5% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the FRA:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
88GF Score

Get the complete analysis for FRA:QTS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€164.40
Price
€220.53
GF Value